HTGM Annual ROE
-273.50%
-135.70%-98.48%
31 December 2022
Summary:
As of January 19, 2025, HTGM annual return on equity is -273.50%, with the most recent change of -135.70% (-98.48%) on December 31, 2022. During the last 3 years, it has fallen by -187.85% (-219.32%).HTGM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HTGM Quarterly ROE
-421.36%
-102.27%-32.05%
31 March 2023
Summary:
As of January 19, 2025, HTGM quarterly return on equity is -421.36%, with the most recent change of -102.27% (-32.05%) on March 31, 2023. Over the past year, it has dropped by -290.55% (-222.12%).HTGM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HTGM ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.5% | -222.1% |
| 3 y3 years | -219.3% | -342.1% |
| 5 y5 years | -144.1% | +50.5% |
HTGM ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -144.1% | -111.4% |
HTG Molecular Diagnostics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -421.36%(+32.1%) |
| Dec 2022 | -273.50%(+98.5%) | -319.09%(+25.2%) |
| Sept 2022 | - | -254.92%(+39.9%) |
| June 2022 | - | -182.18%(+39.3%) |
| Mar 2022 | - | -130.81%(+14.5%) |
| Dec 2021 | -137.80%(+26.9%) | -114.22%(+13.7%) |
| Sept 2021 | - | -100.45%(-0.9%) |
| June 2021 | - | -101.39%(-11.8%) |
| Mar 2021 | - | -114.96%(+4.9%) |
| Dec 2020 | -108.55%(+26.7%) | -109.55%(+13.8%) |
| Sept 2020 | - | -96.29%(-1.0%) |
| June 2020 | - | -97.26%(+2.1%) |
| Mar 2020 | - | -95.30%(-0.4%) |
| Dec 2019 | -85.65%(-53.1%) | -95.65%(+11.9%) |
| Sept 2019 | - | -85.44%(-1.5%) |
| June 2019 | - | -86.74%(+24.6%) |
| Mar 2019 | - | -69.62%(-16.2%) |
| Dec 2018 | -182.49% | -83.09%(-24.9%) |
| Sept 2018 | - | -110.68%(-35.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | -171.07%(-79.9%) |
| Mar 2018 | - | -851.06%(-325.4%) |
| Dec 2017 | 619.71%(-234.5%) | 377.57%(-6.0%) |
| Sept 2017 | - | 401.61%(-14.4%) |
| June 2017 | - | 468.92%(-30.3%) |
| Mar 2017 | - | 673.23%(-222.4%) |
| Dec 2016 | -460.86%(+263.9%) | -550.12%(+118.2%) |
| Sept 2016 | - | -252.11%(+65.9%) |
| June 2016 | - | -151.94%(-96.5%) |
| Mar 2016 | - | -4355.10%(+1873.1%) |
| Dec 2015 | -126.66%(-318.2%) | -220.72%(-106.0%) |
| Sept 2015 | - | 3680.47%(+2416.4%) |
| June 2015 | - | 146.26%(+145.6%) |
| Mar 2015 | - | 59.54%(+3.7%) |
| Dec 2014 | 58.06%(+10.7%) | 57.40%(+8.4%) |
| Sept 2014 | - | 52.96%(+29.9%) |
| June 2014 | - | 40.76%(+67.4%) |
| Mar 2014 | - | 24.35%(+107.2%) |
| Dec 2013 | 52.43%(-25.1%) | 11.75% |
| Dec 2012 | 69.96% | - |
FAQ
- What is HTG Molecular Diagnostics annual return on equity?
- What is the all time high annual ROE for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics annual ROE year-on-year change?
- What is HTG Molecular Diagnostics quarterly return on equity?
- What is the all time high quarterly ROE for HTG Molecular Diagnostics?
- What is HTG Molecular Diagnostics quarterly ROE year-on-year change?
What is HTG Molecular Diagnostics annual return on equity?
The current annual ROE of HTGM is -273.50%
What is the all time high annual ROE for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high annual return on equity is 619.71%
What is HTG Molecular Diagnostics annual ROE year-on-year change?
Over the past year, HTGM annual return on equity has changed by -135.70% (-98.48%)
What is HTG Molecular Diagnostics quarterly return on equity?
The current quarterly ROE of HTGM is -421.36%
What is the all time high quarterly ROE for HTG Molecular Diagnostics?
HTG Molecular Diagnostics all-time high quarterly return on equity is 3680.47%
What is HTG Molecular Diagnostics quarterly ROE year-on-year change?
Over the past year, HTGM quarterly return on equity has changed by -290.55% (-222.12%)